Notice Director’s Report Management Discussion Report on Corporate Auditor’s Report
Balance Sheet Profit and Loss Notes Forming Case Flow Proxy Form

STATEMENT OF PROFIT AND LOSS

COLINZ LABORATORIES LTD.

STATEMENT OF PROFIT AND LOSS  FOR THE YEAR ENDED MARCH 31, 2013

All amounts in Rupees, unless otherwise stated
 Year ended   Year ended 
NOTES  March 31, 2013   March 31, 2012 
 I  Revenue from Operations
Sales -Products 15
                76,818,336
70,454,561
Other Operating Revenue
323,373
                               -
Less : Excise duty
               (5,282,156)
               (4,435,470)
71,859,553 66,019,091
   
 II  Other Income 16
                     774,599
                     368,554
 III   Total Revenue (I+II) 
               72,634,152
24,417,414
 IV  Expenses
Cost of Materials Consumed 17
21,401,546
                 24,417,414
Purchase of Trading Goods
                  5,459,923
                  3,457,117
Changes in inventories of finished goods work-in-progress and Stock-in-Trade 18
1,701,784
(1,095,212)
Employee Benefits Expense 19
                 25,748,545
                 22,543,606
Finance Cost 20
                  2,020,580
                  1,892,853
Depreciation and amortization expense 7
                  2,619,303
                  2,599,469
Other Expenses 21
                 12,082,689
                 11,693,676
 Total Expenses                 71,034,370                65,508,921
 V  Profit before exceptional and extraordinary items and tax (III-IV)                    
                 1,599,782
                   
                    878,724
 VI  Exceptional items                              -                                -
 VII  Profit before extraordinary items and tax (V - VI)
                 1,599,782
                    878,724
 VIII  Extraordinary Items                              -                                 -
 IX  Profit before tax (VII- VIII)
                 1,599,782
                    878,724
 X  Tax expense:
(1) Current tax
                    297,283
                    158,337
(2) Deferred tax
                    504,139
(383863)
 XI  Profit (Loss) for the period from continuing operations (IX-X)
                    798,360
                 1,104,250
 XII  Profit/(loss) from discontinuing operations                              -                                  -
 XIII  Tax expense of discontinuing operations                              -                                  -
 XIV  Profit/(loss) from Discontinuing operations (after tax) (XII-XIII)                              -                                  -
 XV  Profit (Loss) for the period (XI + XIV)                  798,360              1,104,250
 XVI  Earnings per equity share:
(1) Basic                           0.17                           0.24
(2) Diluted                              -  
Significant accounting policies and notes  1
 to the financial statements 

 

As per our report of even date attached.    
FOR  S. V. BHAT & CO. FOR AND ON BEHALF OF THE BOARD.
FIRM REG.NO.101298W  
Chartered Accountants.    
     
S. V. BHAT Dr.  L. S. Mani N. K. MENON
Proprietor.  Chairman & Managing Director Director
M. No. 37237 .  
   
Place: Mumbai    
Date:15th May, 2013.    

 

(Top)

Contact:
A/101, Pratik Estate,
Mulund Link Road,
Next to Fortis Hospital,
Mumbai-400078.
Tel.: 91-22-25668002/3
Fax: 91-22-25668006.
Email: cllfindoc@yahoo.com
Website:www.findoc-cll.in
Email:info@findoc-cll.in